MessageCompany OverviewCorporate PhilosophyHistoryNews ReleaseMap

Press Release

2008.6.11ReqMed, bene pharmaChem GmbH & Co., KG and Asahi Kasei Pharma Corporation announce the exclusive license agreement on Sodium Pentosan Polysulfate.

News Release

2007.02.12R&D FOCUS drugnews
volume 16 No.7
Updates from ReqMed
· ADHD therapy, ReqMed/Psychogenics
· injectable pentosan polysulfate sodium,ReMed4
2006.05.08BioWorld TodayHow Frustrated Firm ReqMed Created New Biotech Strategy
Bridgingng Drug Development Gap Z
2006.01.30PHARMA JAPAN
1997 p.17
JPLA Seminar
Bioventures, Pharma Companies Working Together More Closely
Vol. 99, Issue 26
Protection against ischemic brain injury by protein therapeutics
2000.12.15International Herald Tribune
Japanese Try to Bridge The Biotechnology Gap
Government Earmarks Funds for Start-up

Copyright (C) 2008 ReqMed Company, Ltd. All Rights Reserved.